Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates

Listen Now

Topics Covered

• Overview of Acute Lymphocytic/Lymphoblastic Leukemia (ALL) in Adults
• Current Standard of Care
• Treatment Updates
• Therapy for Relapsed/Refractory ALL
• New Treatment Approaches & Targeted Therapy
• Clinical Trial Updates
• How Research Contributes to Treatment Options
• Managing Complications & Side Effects of ALL & its Treatment
• Quality-of-Life Concerns
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of OpenNotes
• Questions for Our Panel of Experts

Our Panel of Experts

Marlise R. Luskin, MD, MSCE

Senior Physician, Dana-Farber Cancer Institute, Assistant Professor of Medicine, Harvard Medical School

Emily Curran, MD

Assistant Professor, Division of Hematology/Oncology, Medical Director, UCCC Clinical Trials Office, University of Cincinnati Cancer Center, Vontz Center for Molecular Studies

Kevin Radelet

Executive Director, Leukemia Research Foundation

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on March 01, 2024.